<DOC>
	<DOCNO>NCT00798759</DOCNO>
	<brief_summary>The purpose study compare two ophthalmic solution patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Examination Ocular Surface Effects With Administration Travatan Z XALATAN</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>18 year old . Diagnosis openangle glaucoma ocular hypertension least one eye . Intraocular pressure ( IOP ) control BAK ( benzalkonium chloride ) preserve IOPlowering medication 1 year , last 6 month XALATANÂ® monotherapy . Best correct visual acuity 0.6 logMAR good eye . Other protocoldefined inclusion criterion may apply . Treatment BAK preserve artificial tear within 30 day Visit 1 . Known suspected Sjogren 's disease . Uncontrolled IOP . History evidence infectious inflammatory ocular condition . Progressive retinal optic nerve disease . Ocular laser surgery within 3 month Visit 1 . Keratorefractive ocular laser procedure , corneal surgery surgery corneal surface within 1 year Visit 1 . Current use punctal plug punctal cautery . Use systemic medication stable 30 day prior Visit 1 . Use contact lens within 30 day Visit 1 . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Open-angle glaucoma</keyword>
	<keyword>Ocular hypertension</keyword>
</DOC>